KFDA restricts use of buflomedil preparations

Published: 2011-02-22 06:58:00

Updated: 2011-02-22 06:58:00

The Korea Food and Drug Administration said recently that it imposes new restrictions on the use of a vasodilator buflomedil in an effort to protect patients from the risks of neurological and heart problems.

The administration ordered doctors to refrain from prescribing it for patients.

Th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK